CM Ingerman
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacology and Obesity Treatment
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Co-authors
- M.J. Silver (6 shared papers)J B Smith (1 shared paper)J. Bryan Smith (7 shared papers)James J. Kocsis (2 shared papers)Sandor S. Shapiro (2 shared papers)MJ Silver (2 shared papers)Albert W. Sedar (1 shared paper)K.C. Nicolaou (1 shared paper)
- Journals
- Blood (2 papers)Prostaglandins (2 papers)Advances in experimental medicine and biology (1 paper)The Lancet (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United States
In The Last Decade
CM Ingerman
9 papers receiving 660 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 321
- Biochemistry 144
- Hematology 136
- Cardiology and Cardiovascular Medicine 244
- Internal Medicine 35
Countries citing papers authored by CM Ingerman
This map shows the geographic impact of CM Ingerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CM Ingerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CM Ingerman more than expected).
Fields of papers citing papers by CM Ingerman
This network shows the impact of papers produced by CM Ingerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CM Ingerman. The network helps show where CM Ingerman may publish in the future.
Co-authors
The 13 scholars most cited alongside CM Ingerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Malondialdehyde formation as an indicator of prostaglandin production by human platelets. | 1976 | 325 |
| 2 | 1973 | 251 | |
| 3 | 1976 | 53 | |
| 4 | 1978 | 47 | |
| 5 | 1978 | 37 | |
| 6 | 1975 | 24 | |
| 7 | 1977 | 17 | |
| 8 | A model system for studying initial events in atherosclerosis. | 1980 | 4 |
| 9 | 1978 | 1 |
About CM Ingerman
CM Ingerman is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Physiology, Speech and Hearing and Biochemistry, having authored 9 papers that have together received 759 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Neonatal Health and Biochemistry (2 papers), Adolescent and Pediatric Healthcare (2 papers), Adenosine and Purinergic Signaling (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Pharmacology (321 citations), Biochemistry (144 citations), Hematology (136 citations), Cardiology and Cardiovascular Medicine (244 citations) and Internal Medicine (35 citations). CM Ingerman has collaborated with scholars based in United States. Frequent co-authors include M.J. Silver, J B Smith, J. Bryan Smith, James J. Kocsis, Sandor S. Shapiro, MJ Silver, Albert W. Sedar, K.C. Nicolaou, William J. Sipio and William E. Barnette. Their work appears in journals such as Blood, Prostaglandins, Advances in experimental medicine and biology, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.